# [Project name]

> **Outcome label: Grey — Insufficient evidence**
>
> Change this label only when cited project-specific evidence supports an assessment against the original objectives. Do not use colour alone.

## At a glance

| Field | Details |
| --- | --- |
| Location / region | [Add location] |
| Policy area | [Health / education / infrastructure / housing / cost of living / other] |
| Responsible agencies | [Add agencies] |
| Delivery partners | [Add partners, if applicable] |
| Project timeline | [Approval, start, major milestones, completion/current status] |
| Reporting updated | [Date] |

## Need and rationale

- **Problem or need:** [What issue was the project intended to address?]
- **Reason for funding:** [What reasons did decision-makers give? Cite the decision documents.]
- **Alternatives considered:** [What other options were assessed, including doing nothing?]

## Approved scope, cost and expected benefits

- **Original scope:** [Define what was approved and what was excluded.]
- **Approved funding and budget basis:** [Amount, approval date, funding source and whether figures are nominal or inflation-adjusted.]
- **Expected benefits:** [State measurable benefits, target groups, baselines and target dates.]

## Delivery and changes

| Date | Decision or change | Effect on scope, cost or schedule | Source |
| --- | --- | --- | --- |
| [Date] | [Approved change, milestone or review] | [Explain against the original baseline] | [Link and document details] |

Summarise delivery status, delays, scope changes, cost changes and reasons. Preserve the original approved baseline when describing later re-estimates.

## Outcomes against objectives

| Original objective | Measure and baseline | Result / latest status | Evidence and limitations |
| --- | --- | --- | --- |
| [Objective] | [Measure, baseline and target date] | [Observed result or not yet known] | [Evaluation/source, reporting period, limitations] |

**Assessment:** [Explain whether the main intended outcomes were achieved, partly achieved, not achieved, still in progress, or cannot yet be assessed. Distinguish observed results from demonstrated project impact.]

**Who benefited or was affected:** [Describe evidence across relevant populations and locations, including material adverse effects.]

## Further funding, repetition or discontinuation

[Was the project repeated, expanded, re-scoped or given additional funding? Explain the stated reason, new approvals and evidence of performance. If cancelled or discontinued, document what was delivered, remaining costs or liabilities, and the decision rationale.]

Discuss sunk costs separately from future costs and benefits. Expenditure already incurred is not, by itself, a reason to continue or stop.

## Sources

1. [Primary source: title, publisher, publication date, reporting period and direct link]
2. [Independent evaluation, audit or review: title, publisher, date and direct link]

## Editorial notes

- **Assessment method:** [Explain how the label follows from the objectives and evidence.]
- **Uncertainties / evidence gaps:** [State missing or contested information.]
- **Last reviewed:** [Date]